Red heart brought some luck and few followers it seems , well done Architect hope it’s not a short lived pump. 2 weeks before any appeals but in worst case they ll speed up the new project acquisition …
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
